Open access
Aug 2026
Human iPSC-derived neural progenitor gene therapy improves outcomes in a neuropathic lysosomal disease.
A neural stem cell gene therapy that achieves high enzyme delivery and restores cognitive function, likely through integration of healthy neural cells across multiple brain regions is reported, offering a promising therapeutic avenue for MPS IIIA and broader lysosomal storage disorders.
Oriana Mandolfo, Yuko Ishikawa Learmonth, Asma’u Usman et al.
· Molecular Therapy · 0 citations